Latest Pharma Insights
India: Big Pharma’s Strategic Pivot, Key 2025 Launches And What’s Coming
2025 saw star products debut in India as foreign firms doubled down on high-value, IP-protected therapies. Experts tell Scrip the top 10 cities in the country can now sustain “US/EU-style” specialty launches.
Scrip - January 7, 2026
2025 saw star products debut in India as foreign firms doubled down on high-value, IP-protected therapies. Experts tell Scrip the top 10 cities in the country can now sustain “US/EU-style” specialty launches.
Scrip - January 7, 2026
Makary Touts ‘AI Revolution,’ Announces Guidance Docs On Wellness Products, Decision Support Tool
FDA Commissioner Marty Makary announced new guidance documents on wellness products and decision support tools focused on AI technology at CES in Las Vegas. The documents aim to reduce regulatory hurdles and promote innovation while ensuring public safety.
HBW Insight - January 7, 2026
FDA Commissioner Marty Makary announced new guidance documents on wellness products and decision support tools focused on AI technology at CES in Las Vegas. The documents aim to reduce regulatory hurdles and promote innovation while ensuring public safety.
HBW Insight - January 7, 2026
Makary Touts ‘AI Revolution’ In Announcing Guidance Docs On Wellness Products, Decision Support Tool
FDA Commissioner Marty Makary announced new guidance documents on wellness products and decision support tools focused on AI technology at CES in Las Vegas. The documents aim to reduce regulatory hurdles and promote innovation while ensuring public safety.
Medtech Insight - January 7, 2026
FDA Commissioner Marty Makary announced new guidance documents on wellness products and decision support tools focused on AI technology at CES in Las Vegas. The documents aim to reduce regulatory hurdles and promote innovation while ensuring public safety.
Medtech Insight - January 7, 2026
India: Big Pharma’s Strategic Pivot, Key 2025 Launches And What’s Coming
2025 saw star products debut in India as foreign firms doubled down on high-value, IP-protected therapies. Experts tell Scrip the top 10 cities in the country can now sustain “US/EU-style” specialty launches.
Scrip - January 7, 2026
2025 saw star products debut in India as foreign firms doubled down on high-value, IP-protected therapies. Experts tell Scrip the top 10 cities in the country can now sustain “US/EU-style” specialty launches.
Scrip - January 7, 2026
Makary Touts ‘AI Revolution’ In Announcing Guidance Docs On Wellness Products, Decision Support Tool
FDA Commissioner Marty Makary announced new guidance documents on wellness products and decision support tools focused on AI technology at CES in Las Vegas. The documents aim to reduce regulatory hurdles and promote innovation while ensuring public safety.
Medtech Insight - January 7, 2026
FDA Commissioner Marty Makary announced new guidance documents on wellness products and decision support tools focused on AI technology at CES in Las Vegas. The documents aim to reduce regulatory hurdles and promote innovation while ensuring public safety.
Medtech Insight - January 7, 2026
Makary Touts ‘AI Revolution,’ Announces Guidance Docs On Wellness Products, Decision Support Tool
FDA Commissioner Marty Makary announced new guidance documents on wellness products and decision support tools focused on AI technology at CES in Las Vegas. The documents aim to reduce regulatory hurdles and promote innovation while ensuring public safety.
HBW Insight - January 7, 2026
FDA Commissioner Marty Makary announced new guidance documents on wellness products and decision support tools focused on AI technology at CES in Las Vegas. The documents aim to reduce regulatory hurdles and promote innovation while ensuring public safety.
HBW Insight - January 7, 2026
Alvotech Confirms CEO Handover As Wessman Passes Role To Graver
Alvotech has unveiled a planned leadership transition, with founder and chairman Róbert Wessman handing the chief executive role to long-time collaborator Lisa Graver as the biosimilars specialist prepares for its next phase of growth.
Generics Bulletin - January 6, 2026
Alvotech has unveiled a planned leadership transition, with founder and chairman Róbert Wessman handing the chief executive role to long-time collaborator Lisa Graver as the biosimilars specialist prepares for its next phase of growth.
Generics Bulletin - January 6, 2026
Aurobindo Breaks Off Ustekinumab Deal With BioFactura Amid Strategic Rethink
Two and a half years after striking a partnership deal with BioFactura for the firm’s ustekinumab biosimilar rival to Stelara, Aurobindo’s CuraTeQ subsidiary has terminated the agreement in line with its “strategic portfolio prioritization.”
Generics Bulletin - January 6, 2026
Two and a half years after striking a partnership deal with BioFactura for the firm’s ustekinumab biosimilar rival to Stelara, Aurobindo’s CuraTeQ subsidiary has terminated the agreement in line with its “strategic portfolio prioritization.”
Generics Bulletin - January 6, 2026
EU’s Biotech Act Draft Lacks ‘Competition-Driven’ Biosimilar Policies, Warns Medicines For Europe
The European Commission sees the value of biosimilars, but its biotech vision lacks competitive incentives to build on the region’s relevance.
Generics Bulletin - January 6, 2026
The European Commission sees the value of biosimilars, but its biotech vision lacks competitive incentives to build on the region’s relevance.
Generics Bulletin - January 6, 2026
Podcast: Building A Nasal First Line Of Defense Against H5N1
Intranasal H5N1 vaccine experts discuss Phase I data, mucosal immunity, BARDA/NIH funding realities and how BlueWillow Biologics' NanoVax platform could strengthen global pandemic flu preparedness and respiratory defenses.
In Vivo - January 6, 2026
Intranasal H5N1 vaccine experts discuss Phase I data, mucosal immunity, BARDA/NIH funding realities and how BlueWillow Biologics' NanoVax platform could strengthen global pandemic flu preparedness and respiratory defenses.
In Vivo - January 6, 2026